Results 191 to 200 of about 191,849 (243)

Role for inflammatory markers in predicting right ventricular failure in mechanical assist device recipients

open access: yesESC Heart Failure, EarlyView.
Abstract Right ventricular failure (RVF) is a common complication following left ventricular assist device (LVAD) implantation and increases patient morbidity and mortality. Due to the complex and limited understanding of RVF pathophysiology, efforts to prognosticate RVF after LVAD have been challenging.
Abdul‐Fatawu Osman   +11 more
wiley   +1 more source

Transcatheter aortic valve replacement in heavily calcified aortic valve stenosis: a multicenter comparison. [PDF]

open access: yesClin Res Cardiol
Saad M   +18 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Amplitude fluctuations of cerebrovascular oscillations and CSF movement desynchronize during NREM3 sleep. [PDF]

open access: yesJ Cereb Blood Flow Metab
Nair VV   +6 more
europepmc   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy